Aller au contenu principal
2022 conference-abstract

Abstract 15458: Incidence of Ventricular Arrhythmias Related to Covid Infection and Vaccination in Patients With Brugada Syndrome: Insights From a Large Italian Multicenter Study

0Citations signalées — pas une note de qualité
9Institutions déclarées
1Pays d’affiliation déclarés

Résumé fourni par la source

Introduction: Brugada syndrome (BrS) is an inherited channelopathy leading to an increased risk of life-threatening arrhythmias. BrS patients have a dynamic ECG pattern that might be revealed by certain conditions such as fever. Covid infection/vaccination is associated with fever. Therefore, prompt treatment with antipyretic drugs is recommended. Hypothesis: We evaluated the incidence and management of fever-related arrhythmias from Covid infection/vaccination among BrS patients previously implanted with an implantable loop recorder (ILR) or an implantable cardioverter-defibrillator (ICD) and followed by remote monitoring. Methods: 326 patients were retrospectively analyzed in 9 Italian Centers with a dedicated inherited disease ambulatory. All patients had a previously implanted device (ICD/ILR) and remote monitoring. We recorded ventricular arrhythmias (non-sustained VT, VT, FVT, VF) 6-month before Covid infection/vaccination, during Covid infection, at each vaccination, and up to 6-month post-Covid healing or 1-month after the last dose of vaccine. In ICD patients, we documented any device intervention (ATP/shock). Results: Mean age was 48.02±14.08, 240 patients were males (73.6%). 235 patients had an ICD (72.1%), and 91 had an ILR (27.9%). 175 patients had a spontaneous type 1 ECG pattern (53.7%). Fever occurred in 18.4% of all patients. The mean temperature was 38.2±0.6 degrees, 2.76% were hospitalized due to Covid. All patients developing fever received paracetamol, only a minority ibuprofen, antibiotics, and hydroxychloroquine. After Covid, we recorded 2 VT episodes in the same patient treated with paracetamol and hydroxychloroquine. After the 1st, 2nd, and 3rd vaccine doses we recorded: 10 NSVT; 16 NSVT and 2 VT; and 7 NSVT, respectively. After 1-month from the last dose, only 1 patient had an episode of FVT. The overall incidence of sustained VT is 1.2%. No ICD interventions, ATP and shocks, were recorded in the ICD population. Patients with an ILR had no ventricular arrhythmias. Conclusions: From this large multicenter study, fever treatment in patients with BrS is widely performed with paracetamol. The overall incidence of sustained ventricular arrhythmias after Covid infection/vaccination is relatively low.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Abstract 15458: Incidence of Ventricular Arrhythmias Related to Covid Infection and Vaccination in Patients With Brugada Syndrome: Insights From a Large Italian Multicenter Study
Date Crossref
08/11/2022
Éditeur
Ovid Technologies (Wolters Kluwer Health)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Cardiac electrophysiology and arrhythmiasViral Infections and Immunology ResearchSARS-CoV-2 and COVID-19 Research

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.